Autotaxin Inhibitor (CRT0273750) Small Molecule (Collaborative Toolkit)

Contributors

Unfortunately this tool is not currently available through our online checkout process. Please contact our team directly to obtain further information on accessing this tool.

Enquire about this Tool

If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Request a license

Get technical support

New to CancerTools?

We are a trusted, non-profit platform for cancer research products, part of Cancer Research UK – by sourcing your cancer research tools from us you help fund future cancer research.

Find out more

Related Tools for Small molecules

Cat. #

Tool Name

151832

LIMK inhibitor CRT0105950 Small Molecule (Tool Compound)

Key Info

Cat. #:	151832
Sub-type:	Inhibitor
Availability:	Please enquire for quantities and pricing
Application:	The compounds exhibit low uM potency in breast cancer cells showing dose dependent inhibition of phosphorylation of the LIMK substrate cofilin. Treatment of MDA-MB-231 breast cancer cells with the compounds significantly reduces their ability to invade a matrigel plug in an inverse in vitro invasion assay. Furthermore, the inhibitors effectively reduce fibroblast-led collective invasion in a co-culture organotypic model.

View Tool

151833

Chk2 inhibitor CCT241533 Small Molecule (Tool Compound)

Key Info

Cat. #:	151833
Sub-type:	Inhibitor
Availability:	Please enquire for quantities and pricing
Application:	CCT241533 blocked CHK2 activity in human tumor cell lines in response to DNA damage, as shown by inhibition of CHK2 autophosphorylation at S516, band shift mobility changes, and HDMX degradation. CCT241533 did not potentiate the cytotoxicity of a selection of genotoxic agents in several cell lines. However, this compound significantly potentiates the cytotoxicity of two structurally distinct PARP inhibitors. Clear induction of the pS516 CHK2 signal was seen with a PARP inhibitor alone, and th…

View Tool

151879

AKR1C3 inhibitor CRT0083914 Small Molecule (Tool Compound)

Key Info

Cat. #:	151879
Sub-type:	Inhibitor
Availability:	Please enquire for quantities and pricing

View Tool

152754

CDK2 inhibitor NU6301 Small Molecule (Tool Compound)

Key Info

Cat. #:	152754
Sub-type:	Inhibitor
Availability:	Please enquire for quantities and pricing
Application:	The prodrug NU6301 rapidly generated NU6102 in vitro in mouse plasma, and tumour NU6102 levels in vivo consistent with activity in vitro. Eight or 12 hourly dosing of 120 mg/kg NU6301 for 10 days was well tolerated in SKUT-1B tumour-bearing mice and inhibited Rb phosphorylation in tumour tissue. Two (8 hourly dosing) and 3 (12 hourly dosing) day tumour growth delay was observed (p=0.04 and p=0.007, respectively) following NU6301 administration. NU6102 selectively inhibited the growth of CDK2 WT (wild type) versus KO MEFs (knockout mouse embryo fibroblasts) (GIââ (concentration required to inhibit cell growth by 50%) 14 ÎźM versus >30 ÎźM), and was more growth-inhibitory in p53 mutant or null versus p53 WT cells (p=0.02), and in Rb (retinoblastoma protein) WT SKUT-1B versus SKUT 1 Rb deficient cells (p=0.01). In SKUT-1B cells NU6102 induced a G2 arrest, inhibition of Rb phosphorylation and cytotoxicity (LCââ 2.6 ÎźM for a 24h exposure).

View Tool

153356

Extracellular signal-related protein kinase 5 ERK5 Small Molecule (Collaborative Toolkit)

Key Info

Cat. #:	153356
Sub-type:	Inhibitor
Availability:	Please enquire for quantities and pricing

View Tool

By Category

By Cancer Type

More

Autotaxin Inhibitor (CRT0273750) Small Molecule (Collaborative Toolkit)

Contributors

Related Tools for Small molecules

Tool enquiry